PIK3CA mutations in breast cancer are associated with poor outcome

Author： Li Shao   Rong Minna   Grieu Fabienne   Iacopetta Barry  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.96, Iss.1, 2006-03, pp. : 91-95

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PIK3CA Exon 20 Mutation is Independently Associated with a Poor Prognosis in Breast Cancer Patients

By Lai Yuen-Liang  

Annals of Surgical Oncology, Vol. 15, Iss. 4, 2008-04 ,pp. : 1064-1069

Springer Publishing Company

Access to resources Recommend Favorite

PIK3CA expression in invasive breast cancer: a biomarker of poor prognosis

By Aleskandarany Mohammed  

Breast Cancer Research and Treatment, Vol. 122, Iss. 1, 2010-07 ,pp. : 45-53

Springer Publishing Company

Access to resources Recommend Favorite

Mutations of the PIK3CA gene in ovarian and breast cancer

By Bellacosa Alfonso  

The Women's Oncology Review, Vol. 5, Iss. 4, 2005-12 ,pp. : 223-225

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer

By Razis E.  

Breast Cancer Research and Treatment, Vol. 128, Iss. 2, 2011-07 ,pp. : 447-456

Springer Publishing Company

Access to resources Recommend Favorite

PIK3CA Mutations and BRCA1 Expression in Breast Cancer: Potential Biomarkers for Chemoresistance

By Santarpia Mariacarmela   Altavilla Giuseppe   Margeli Mireia   Cirauqui Beatriz   Mesiti Mario   Cavallari Vittorio   Ramirez Jose Luis   Sanchez-Ronco Maria   Santarpia Libero   Taron Miquel   Rosell Rafael  

Cancer Investigation, Vol. 26, Iss. 10, 2008-12 ,pp. : 1044-1051

Informa Healthcare

Access to resources Recommend Favorite